Purpose of Technology

Robotically assisted hysterectomy is intended for the minimally invasive removal of the uterus as a treatment for various medical conditions, including endometriosis, uterine fibroids, uterine prolapse, cervical cancer, and uterine cancer.

Questions addressed in this report include:

• How does robotically assisted hysterectomy compare with other surgical techniques in terms of impact on operative and health outcomes?
• Is robotically assisted hysterectomy safe?
• Have definitive patient selection criteria been established for robotically assisted hysterectomy?

These questions provide a framework for review and synthesis of the best available evidence, which is presented in this report, along with the Hayes Ratings for the technology. This report also provides background information about the condition being treated, a description of the technology, and the context for development of the technology. Other key elements addressed in the report include the regulatory status; applicable Medicare and commercial payer coverage policies; relevant ICD-9 and ICD-10 diagnosis codes; cost and cost effectiveness; credentialing; hospital length of stay; need for large case management; and ongoing and future clinical trials of the technology.

Posted in Directory Reports
This entry was posted on Monday, June 7th, 2010 at 12:00 pm.